It is now suggested that TGF-β has biphasic effects during tumorigenesis, initially acting as a tumour suppressor, but later stimulating cancer progression (Akhurst and Balmain, 1999; Akhurst and Derynck, 2001). The gene discussed is TGFB1; the disease is cancer.